Todd W. Garner's most recent trade in Conmed Corp. was a trade of 371 Common Stock done at an average price of $57.4 . Disclosure was reported to the exchange on March 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 57.37 per share. | 31 Mar 2025 | 371 | 598 (0%) | 0% | 57.4 | 21,284 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 61,475 | 61,475 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 22,727 | 22,727 | - | - | RSUs (Restricted Stock Units) | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 76.08 per share. | 28 Mar 2024 | 227 | 227 (0%) | 0% | 76.1 | 17,270 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 44,677 | 44,677 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 112.00 per share. | 16 Aug 2023 | 1,355 | 0 (0%) | 0% | 112 | 151,760 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 98.67 per share. | 31 Mar 2023 | 240 | 1,355 (0%) | 0% | 98.7 | 23,681 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.61 per share. | 13 Mar 2023 | 30,000 | 31,115 (0%) | 0% | 50.6 | 1,518,300 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 30,000 | 5,100 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 91.10 per share. | 13 Mar 2023 | 17,926 | 5,040 (0%) | 0% | 91.1 | 1,633,075 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 90.30 per share. | 13 Mar 2023 | 6,849 | 22,966 (0%) | 0% | 90.3 | 618,495 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 91.95 per share. | 13 Mar 2023 | 3,825 | 1,215 (0%) | 0% | 91.9 | 351,690 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 88.78 per share. | 13 Mar 2023 | 1,300 | 29,815 (0%) | 0% | 88.8 | 115,416 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 92.63 per share. | 13 Mar 2023 | 100 | 1,115 (0%) | 0% | 92.6 | 9,263 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 32,212 | 32,212 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,600 | 1,601 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,600 | 0 | - | - | Rsus (restricted Stock Units) | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.16 per share. | 01 Mar 2023 | 486 | 1,115 (0%) | 0% | 96.2 | 46,734 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 89.31 per share. | 09 Dec 2022 | 4,500 | 1 (0%) | 0% | 89.3 | 401,895 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 4,500 | 35,100 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.61 per share. | 09 Dec 2022 | 4,500 | 4,501 (0%) | 0% | 50.6 | 227,745 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 91.00 per share. | 30 Jun 2022 | 1 | 1 (0%) | 0% | 91 | 91 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 99.79 per share. | 13 Jun 2022 | 2,662 | 0 (0%) | 0% | 99.8 | 265,641 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 141.12 per share. | 31 Mar 2022 | 168 | 2,662 (0%) | 0% | 141.1 | 23,708 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 55,000 | 55,000 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 1,600 | 2,963 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 1,600 | 1,600 | - | - | Rsus (restricted Stock Units) | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.55 per share. | 01 Mar 2022 | 469 | 2,494 (0%) | 0% | 144.6 | 67,794 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 2,000 | 0 | - | - | Rsus (restricted Stock Units) | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 145.86 per share. | 03 Jan 2022 | 637 | 1,363 (0%) | 0% | 145.9 | 92,913 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2021 | 8,400 | 39,600 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.61 per share. | 04 Oct 2021 | 8,400 | 8,400 (0%) | 0% | 50.6 | 425,124 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 129.38 per share. | 04 Oct 2021 | 3,117 | 5,283 (0%) | 0% | 129.4 | 403,271 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 130.05 per share. | 04 Oct 2021 | 3,083 | 2,200 (0%) | 0% | 130.0 | 400,938 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 132.65 per share. | 04 Oct 2021 | 900 | 500 (0%) | 0% | 132.7 | 119,386 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 131.49 per share. | 04 Oct 2021 | 800 | 1,400 (0%) | 0% | 131.5 | 105,194 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 133.45 per share. | 04 Oct 2021 | 500 | 0 (0%) | 0% | 133.4 | 66,723 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 130.12 per share. | 04 Oct 2021 | 81 | 52 (0%) | 0% | 130.1 | 10,540 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 129.33 per share. | 04 Oct 2021 | 58 | 133 (0%) | 0% | 129.3 | 7,501 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 133.00 per share. | 04 Oct 2021 | 32 | 0 (0%) | 0% | 133 | 4,256 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 131.65 per share. | 04 Oct 2021 | 20 | 32 (0%) | 0% | 131.7 | 2,633 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 124.92 per share. | 15 Sep 2021 | 1,131 | 191 (0%) | 0% | 124.9 | 141,285 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 122.76 per share. | 13 Aug 2021 | 1,350 | 1,322 (0%) | 0% | 122.8 | 165,726 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 137.04 per share. | 15 Jun 2021 | 960 | 2,672 (0%) | 0% | 137.0 | 131,558 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 May 2021 | 1,312 | 3,632 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 141.19 per share. | 14 May 2021 | 1,257 | 4,944 (0%) | 0% | 141.2 | 177,476 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 124.06 per share. | 31 Mar 2021 | 191 | 6,201 (0%) | 0% | 124.1 | 23,695 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 45,050 | 45,050 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 1,600 | 6,479 (0%) | 0% | 0 | Common Stock | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 1,600 | 3,200 | - | - | Rsus (restricted Stock Units) | |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.55 per share. | 01 Mar 2021 | 469 | 6,010 (0%) | 0% | 122.6 | 57,476 | Common Stock |
Conmed Corp. | Todd W. Garner | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.35 per share. | 04 Jan 2021 | 650 | 4,879 (0%) | 0% | 111.4 | 72,378 | Common Stock |